Zura Bio Limited
ZURA
$1.23
$0.086.96%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 66.16% | 113.60% | 9.60% | 68.82% | 97.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.30% | 89.64% | -65.32% | 8.55% | -45.37% |
| Operating Income | -45.30% | -89.64% | 65.32% | -8.55% | 45.37% |
| Income Before Tax | -60.80% | -150.33% | 69.64% | 20.91% | 57.58% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -60.80% | -150.33% | 69.64% | 20.91% | 57.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -100.00% |
| Net Income | -60.80% | -150.33% | 69.64% | 19.23% | 53.53% |
| EBIT | -45.30% | -89.64% | 65.32% | -8.55% | 45.37% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 25.41% | -48.92% | 87.09% | 99.43% | 99.79% |
| Normalized Basic EPS | 16.87% | -34.27% | 86.11% | 91.88% | 99.59% |
| EPS Diluted | 25.41% | -48.92% | 87.09% | 99.43% | 99.79% |
| Normalized Diluted EPS | 16.87% | -34.27% | 86.11% | 91.88% | 99.59% |
| Average Basic Shares Outstanding | 93.31% | 86.31% | 118.49% | 1,220.83% | 11,793.00% |
| Average Diluted Shares Outstanding | 93.31% | 86.31% | 118.49% | 1,220.83% | 11,793.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |